News - Pradaxa, Bayer


Current filters:


Popular Filters

Bayer the latest in anticoagulant lawsuit action

Bayer the latest in anticoagulant lawsuit action


German drug major Bayer is just one of the latest companies to be facing lawsuits over its anticoagulants,…

BayerBoehringer IngelheimHematologyHematologyLegalPharmaceuticalPradaxaRivaroxabanUSAWarfarin SodiumXarelto

Briefs: Elan tender offer; German drug price review; Daiichi Sankyo pays milestone


Ireland-based drugmaker Elan (NYSE: ELN) yesterday reported final results of its modified Dutch auction…

ActemraAmgenAnticalinBayerElanFinancialNovo NordiskPharmaceuticalPradaxaPricingProliaRegulationResearchRocheVictozaXarelto

Pradaxa efficacy and cost effectiveness advantages over Xarelto


Indirect comparison based on the RE-LYtrial (for family owned German drugmaker Boehringer Ingelheim's…

BayerBoehringer IngelheimCardio-vascularPharmaceuticalPradaxaPricingResearchXarelto

EU approves Boehringer’s Pradaxa for stroke prevention in atrial fibrillation


There was good news for independent German drug major Boehringer Ingelheim yesterday, when the company…

BayerBoehringer IngelheimCardio-vascularEuropePharmaceuticalPradaxaRegulationXarelto

Back to top